Rodolphe Barrangou is the Todd R. Klaenhammer Distinguished Scholar in Probiotics Research and a professor of food, bioprocessing and nutrition sciences at North Carolina State University. He was a pioneer in discovering CRISPR as an adaptive bacterial immune system, demonstrating that CRISPR sequences defend bacteria against invaders such as bacteriophages, and for more than a decade he and his team have used CRISPR sequences to vaccinate dairy fermentation bacteria against common phage viruses. He has been elected to the National Academy of Sciences, the National Academy of Engineering and the National Academy of Inventors, and his honors include the 2016 Warren Alpert Prize, the 2016 Canada Gairdner International Award and the 2018 National Academy of Sciences Prize in Food and Agriculture Sciences.
Facts
Defining ContributionFirst author of the 2007 Science paper giving experimental proof of the immune function of CRISPR 2 In the Other Atlases
Nationality
Also in Geography Atlas: the nationality of this subject.
Source Wikidata: Rodolphe Barrangou
Sources
1. Wikidata: Rodolphe Barrangou
- Wikidata Q23638664, class allow-list match (w-bbfill-artsarchag-0926 resolve_missing)
- Wikidata Q23638664, P569 claim (w-bbfill-artsarchag-0926)
View the Source2. Rodolphe Barrangou, Wikipedia
Lead, descriptor
French American probiotics researcher
Research section, 2007 Science paper
In 2007, Barrangou was the first author on a paper published in Science providing experimental proof for the immune function of CRISPR.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.